Will Psychedelics Companies Win The Mental Health Boom?

Will Psychedelics Companies Win The Mental Health Boom?
Stéphane Renevier, CFA

almost 2 years ago1 min

If there’s one sector that’s received a huge influx of funding in 2021, it’s global mental health. That’s no surprise: the pandemic led to a significant increase in mental illnesses like anxiety and depression. In fact, 40% of American adults now report struggling with mental health or substance abuse. In response, companies have ramped up research and development to find new treatments. And that creates a market opportunity.

A promising area of new research is in psychedelics: that is, medication based on psychedelic substances like MDMA and LSD. After decades of legal log jams, decriminalization efforts are gaining ground, and research is booming as new startups enter the fast-growing sector almost every month. And sure, psychedelics stocks have taken a heavy beating over the past year – but with all the extra funding, things might be about to change.

One easy way to track companies involved in the research, development, and production of these treatments is via Psylocybin Alpha’s watchlist of publicly-traded psychedelics companies. If you prefer a more passive and diversified approach, a brand new psychedelic ETF has just hit the market: the Horizons ETFs’ North American Psychedelic Stock Index (ticker: PSYK). And don’t forget its two existing competitors: the AdvisorShares Psychedelics ETF (ticker: PSIL) and the Defiance Next Gen Altered Experience ETF (ticker: PSY).



All the daily investing news and insights you need in one subscription.

Disclaimer: These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment advisor.

/3 Your free quarterly content is about to expire. Uncover the biggest trends and opportunities. Subscribe now for 50%. Cancel anytime.

© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG